Clinical Trial

Comparative Experimental Study Between Bupivacaine and Ropivacaine Regarding Efficacy in Third Molar Removal Surgery Under General Anesthesia

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to compare the efficacy of bupivacaine and ropivacaine in third molar removal surgery under general anesthesia in healthy volunteers. The main question aims to determine whether there is any difference in vital signs, hemostasis and postoperative pain between ropivacaine and bupivacaine in patients undergoing third molars extraction under general anesthesia. Researchers will compare bupivacaine and ropivacaine in a split-mouth study to determine if one drug is more effective in third molar extraction surgery under general anesthesia (better hemostasis, less postoperative pain, and fewer changes in vital signs). Participants will undergo a single surgical procedure and complete the Visual Analog Scale to record postoperative pain
Protocol Amendment History 1 change
minor Completion pushed: 2025-12-31 -> 2026-12-31 2026-05-02
Trial Details
NCT Number NCT07108465
Lead Sponsor Henrique Tedesco
Conditions Third Molars Extraction
Enrollment 15 participants
Start Date 2025-07-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-01